Based on 16 analysts giving stock ratings to Globus Medical Inc in the past month.
In the current month, GMED has received 9 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. GMED average Analyst price target in the last month is 103.000.
Based on analysts' estimates, GMED EPS is projected to reach 1.196 in FY2026Q3, following reported EPS of 1.122 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD 1.12, while Globus Medical IncGMED's earnings per share (EPS) for the previous quarter was USD 0.92. EPS for the next quarter is expected at USD 1.20.